Teladoc Health, Inc. (NYSE:TDOC) Stake Raised by MetLife Investment Management LLC

MetLife Investment Management LLC increased its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 3.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 101,612 shares of the health services provider’s stock after buying an additional 3,108 shares during the quarter. MetLife Investment Management LLC owned about 0.06% of Teladoc Health worth $924,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP grew its stake in shares of Teladoc Health by 0.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,531,492 shares of the health services provider’s stock worth $32,104,000 after purchasing an additional 8,890 shares in the last quarter. Canada Pension Plan Investment Board grew its position in Teladoc Health by 0.5% in the 4th quarter. Canada Pension Plan Investment Board now owns 228,700 shares of the health services provider’s stock valued at $2,079,000 after buying an additional 1,200 shares in the last quarter. Farringdon Capital Ltd. acquired a new position in Teladoc Health during the 4th quarter valued at about $149,000. Mariner LLC raised its position in shares of Teladoc Health by 17.3% during the 4th quarter. Mariner LLC now owns 27,065 shares of the health services provider’s stock worth $246,000 after buying an additional 3,982 shares in the last quarter. Finally, Summit Investment Advisors Inc. lifted its stake in shares of Teladoc Health by 8.0% in the 4th quarter. Summit Investment Advisors Inc. now owns 18,009 shares of the health services provider’s stock worth $164,000 after acquiring an additional 1,331 shares during the period. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Adam C. Vandervoort sold 11,011 shares of the company’s stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. This represents a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 0.58% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research firms recently commented on TDOC. Evercore ISI lowered their price objective on shares of Teladoc Health from $8.00 to $7.00 and set an “in-line” rating on the stock in a research note on Thursday. The Goldman Sachs Group cut their price objective on Teladoc Health from $13.00 to $10.00 and set a “buy” rating for the company in a report on Thursday. Bank of America lowered their target price on Teladoc Health from $9.50 to $8.00 and set a “neutral” rating on the stock in a report on Friday, April 11th. Stifel Nicolaus dropped their price target on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Thursday. Finally, Jefferies Financial Group lowered their price objective on shares of Teladoc Health from $10.00 to $8.00 and set a “hold” rating on the stock in a research note on Monday, April 21st. Eleven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Teladoc Health currently has a consensus rating of “Hold” and an average target price of $9.81.

Teladoc Health Stock Up 1.1 %

Teladoc Health stock opened at $7.07 on Friday. Teladoc Health, Inc. has a twelve month low of $6.35 and a twelve month high of $15.21. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The firm has a market cap of $1.24 billion, a PE ratio of -1.23 and a beta of 1.73. The firm’s 50 day moving average price is $8.02 and its two-hundred day moving average price is $9.49.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. On average, research analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.